/#GEO#China Pharmaceutical AI Search#Pharmaceutical AI#Healthcare AI#Pharmaceutical Knowledge Governance#Healthcare Ontology#AI Search Optimization
/ In Q2 2026, Sinohealth MedCortex analyzed approximately 125,000 health-related queries across five major Chinese AI platforms and five leading pharmaceutical categories. The study found that retail market leadership does not automatically translate into AI visibility, AI typically organizes medication within broader healthcare decision pathways, and 95.0% of responses reached a drug-selection direction while only 29.1% reached a commercial brand. This article examines what these findings mean for pharmaceutical GEO, healthcare ontology, and the shift from content visibility to structured pharmaceutical knowledge governance.